Literature DB >> 20461485

Isothermal microcalorimetry as a quality by design tool to determine optimal blending sequences.

M H D Kamal Al-Hallak1, Shirzad Azarmi, Zhenghe Xu, Yadollah Maham, Raimar Löbenberg.   

Abstract

This study was designed to assess the value of isothermal microcalorimetry (ITMC) as a quality by design (QbD) tool to optimize blending conditions during tablet preparation. Powder mixtures that contain microcrystalline cellulose (MCC), dibasic calcium phosphate dihydrate (DCPD), and prednisone were prepared as 1:1:1 ratios using different blending sequences. ITMC was used to monitor the thermal activity of the powder mixtures before and after each blending process. Differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) were performed on all final powder mixtures. Final powder mixtures were used to prepare tablets with 10 mg prednisone content, and dissolution tests were performed on all tablet formulations. Using ITMC, it was observed that the powder mixtures had different thermal activity depending on the blending sequences of the ingredients. All mixtures prepared by mixing prednisone with DCPD in the first stage were associated with relatively fast and significant heat exchange. In contrast, mixing prednisone with MCC in the first step resulted in slower heat exchange. Powder mixture with high thermal activity showed extra DSC peaks, and their dissolution was generally slower compared to the other tablets. Blending is considered as a critical parameter in tablet preparation. This study showed that ITMC is a simple and efficient tool to monitor solid-state reactions between excipients and prednisone depending on blending sequences. ITMC has the potential to be used in QbD approaches to optimize blending parameters for prednisone tablets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461485      PMCID: PMC2895446          DOI: 10.1208/s12248-010-9202-4

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  13 in total

1.  The use of isothermal heat conduction microcalorimetry to evaluate drug stability in tablets.

Authors:  T Selzer; M Radau; J Kreuter
Journal:  Int J Pharm       Date:  1999-07-20       Impact factor: 5.875

Review 2.  Modeling and comparison of dissolution profiles.

Authors:  P Costa; J M Sousa Lobo
Journal:  Eur J Pharm Sci       Date:  2001-05       Impact factor: 4.384

Review 3.  Assessment of disorder in crystalline powders--a review of analytical techniques and their application.

Authors:  G Buckton; P Darcy
Journal:  Int J Pharm       Date:  1999-03-15       Impact factor: 5.875

Review 4.  Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids.

Authors:  Birju Shah; Vasu Kumar Kakumanu; Arvind K Bansal
Journal:  J Pharm Sci       Date:  2006-08       Impact factor: 3.534

Review 5.  Current perspectives in dissolution testing of conventional and novel dosage forms.

Authors:  Shirzad Azarmi; Wilson Roa; Raimar Löbenberg
Journal:  Int J Pharm       Date:  2006-10-06       Impact factor: 5.875

6.  Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.

Authors:  F Tian; F Zhang; N Sandler; K C Gordon; C M McGoverin; C J Strachan; D J Saville; T Rades
Journal:  Eur J Pharm Biopharm       Date:  2006-12-13       Impact factor: 5.571

7.  Pharmaceutical quality by design: product and process development, understanding, and control.

Authors:  Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-10       Impact factor: 4.200

8.  Quality by design: concepts for ANDAs.

Authors:  Robert A Lionberger; Sau Lawrence Lee; Laiming Lee; Andre Raw; Lawrence X Yu
Journal:  AAPS J       Date:  2008-05-09       Impact factor: 4.009

9.  On-line monitoring of powder blend homogeneity by near-infrared spectroscopy.

Authors:  S S Sekulic; H W Ward; D R Brannegan; E D Stanley; C L Evans; S T Sciavolino; P A Hailey; P K Aldridge
Journal:  Anal Chem       Date:  1996-02-01       Impact factor: 6.986

10.  Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.

Authors:  Lin Xie; Huiquan Wu; Meiyu Shen; Larry L Augsburger; Robbe C Lyon; Mansoor A Khan; Ajaz S Hussain; Stephen W Hoag
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

View more
  1 in total

1.  Application of quality by design to the process development of botanical drug products: a case study.

Authors:  Lei Zhang; Binjun Yan; Xingchu Gong; Lawrence X Yu; Haibin Qu
Journal:  AAPS PharmSciTech       Date:  2013-01-08       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.